Yagüe E - Search Results

1

Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.

Asaduzzaman M, Constantinou S, Min H, Gallon J, Lin ML, Singh P, Raguz S, Ali S, Shousha S, Coombes RC, Lam EW, Hu Y, Yagüe E. Asaduzzaman M, et al. Among authors: yague e. Breast Cancer Res Treat. 2017 Jun;163(3):461-474. doi: 10.1007/s10549-017-4202-z. Epub 2017 Mar 24. Breast Cancer Res Treat. 2017. PMID: 28341962 Free PMC article.

2

Isolation and characterization of a cellulose-growth-specific gene from Agaricus bisporus.

Raguz S, Yagüe E, Wood DA, Thurston CF. Raguz S, et al. Among authors: yague e. Gene. 1992 Oct 1;119(2):183-90. doi: 10.1016/0378-1119(92)90270-y. Gene. 1992. PMID: 1398098

3

The cel3 gene of Agaricus bisporus codes for a modular cellulase and is transcriptionally regulated by the carbon source.

Chow CM, Yagüe E, Raguz S, Wood DA, Thurston CF. Chow CM, et al. Among authors: yague e. Appl Environ Microbiol. 1994 Aug;60(8):2779-85. doi: 10.1128/aem.60.8.2779-2785.1994. Appl Environ Microbiol. 1994. PMID: 8085821 Free PMC article.

4

P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation.

Yague E, Armesilla AL, Harrison G, Elliott J, Sardini A, Higgins CF, Raguz S. Yague E, et al. J Biol Chem. 2003 Mar 21;278(12):10344-52. doi: 10.1074/jbc.M211093200. Epub 2003 Jan 13. J Biol Chem. 2003. PMID: 12525496 Free article.

5

Activation of the MDR1 upstream promoter in breast carcinoma as a surrogate for metastatic invasion.

Raguz S, Tamburo De Bella M, Tripuraneni G, Slade MJ, Higgins CF, Coombes RC, Yagüe E. Raguz S, et al. Among authors: yague e. Clin Cancer Res. 2004 Apr 15;10(8):2776-83. doi: 10.1158/1078-0432.ccr-03-0517. Clin Cancer Res. 2004. PMID: 15102684

6

Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1.

Yagüe E, Higgins CF, Raguz S. Yagüe E, et al. Gene Ther. 2004 Jul;11(14):1170-4. doi: 10.1038/sj.gt.3302269. Gene Ther. 2004. PMID: 15164094

7

Expression of RPIP9 (Rap2 interacting protein 9) is activated in breast carcinoma and correlates with a poor prognosis.

Raguz S, De Bella MT, Slade MJ, Higgins CF, Coombes RC, Yagüe E. Raguz S, et al. Among authors: yague e. Int J Cancer. 2005 Dec 20;117(6):934-41. doi: 10.1002/ijc.21252. Int J Cancer. 2005. PMID: 15986426

8

Drug resistance in cancer.

Yagüe E, Raguz S. Yagüe E, et al. Br J Cancer. 2005 Oct 31;93(9):973-6. doi: 10.1038/sj.bjc.6602821. Br J Cancer. 2005. PMID: 16234820 Free PMC article.

9

Ability to acquire drug resistance arises early during the tumorigenesis process.

Yagüe E, Arance A, Kubitza L, O'Hare M, Jat P, Ogilvie CM, Hart IR, Higgins CF, Raguz S. Yagüe E, et al. Cancer Res. 2007 Feb 1;67(3):1130-7. doi: 10.1158/0008-5472.CAN-06-2574. Cancer Res. 2007. PMID: 17283147 Free article.

10

Role of the highly structured 5'-end region of MDR1 mRNA in P-glycoprotein expression.

Randle RA, Raguz S, Higgins CF, Yagüe E. Randle RA, et al. Among authors: yague e. Biochem J. 2007 Sep 15;406(3):445-55. doi: 10.1042/BJ20070235. Biochem J. 2007. PMID: 17573715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters